Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Hospitalier Universitaire de Saint Etienne
With
ARGOS
Association de la Vallée de l'Ondaine
Main aim: To evaluate echographic, doppler and biological markers in a prospective manner as a potential predictive factor of risk of PVP and VTE.
Age
16–50
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
previous history of one or more PVC episodes (preeclampsia, HELLPs, retroplacental hematoma, vascular IUGR\<10th percentile, recurrence miscarriage \>2, unexplained IUFD or IUFD after abruption placentae, eclampsia.
Previous history of personal VTE
Diabete (treated with diet or insulin)
chronic hypertension
chronic renal pathology
lupus
obesity
Antihopholipids syndrome
early and late pregnancy (\<18 years, \>38 years)
family history of cardiovascular disease of VTE
known biological thrombophilia without any personal past history of PVC or VTE
You may not be if
Multiple pregnancy
past history of in utero fetal death due to congenital malformations, rhesus incompatibility or an infection
previous history of IUGR which etiology was a chromosomal, genic or infectious anomaly
